Inactive Instrument
Lipidor AB Stock Nasdaq Stockholm
Stocks
LIPI
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -6.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52% | -24.56% | - | - | 92.63K | |
| -0.56% | -1.52% | +47.86% | +171.88% | 1,060B | |
| +0.31% | -0.60% | +64.37% | +62.31% | 619B | |
| -0.03% | -2.65% | +29.49% | +85.64% | 438B | |
| -1.75% | -0.33% | +28.33% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.19% | +47.26% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -0.81% | -1.63% | +21.35% | +58.33% | 196B | |
| +1.21% | +1.38% | +17.23% | +71.29% | 161B | |
| Average | -1.11% | -3.33% | +25.47% | +56.05% | 397.1B | |
| Weighted average by Cap. | -0.58% | -3.10% | +35.57% | +83.94% |
Employees
4
Sector
Pharmaceuticals
Choose MarketScreener 
